SYK STRYKER CORPORATION

Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day

Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day

Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York.

Stryker’s management will represent the Company in a presentation scheduled for 12:15 p.m. Eastern Time.

A simultaneous webcast and replay of the Company’s presentation will be available on Stryker’s website at .  The webcast will be archived on the Investor Relations page of this site.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at .

Contacts

For investor inquiries please contact:

Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or  

For media inquiries please contact:

Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or



EN
13/02/2025

Underlying

SYKSTRYKER CORPORATION

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRYKER CORPORATION

 PRESS RELEASE
Free
SYK STRYKER CORPORA...

Stryker declares an $0.88 per share quarterly dividend

Stryker declares an $0.88 per share quarterly dividend Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.  “We remain confident in our ability to deliver strong financial performance, and consistent with our capital allocation priorities we are increasing our dividend to $0.88 per share,” said Kevin Lobo...

December 11, 2025 1 EN
 PRESS RELEASE
Free
SYK STRYKER CORPORA...

Stryker names Spencer Stiles President and Chief Operating Officer

Stryker names Spencer Stiles President and Chief Operating Officer Dylan Crotty promoted to Group President, Orthopaedics Portage, Michighan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today Spencer Stiles has been appointed President and Chief Operating Officer (COO), effective January 1, 2026. In this role, Stiles will lead the company’s global businesses, strategy, and mergers and acquisitions. “Appointing Spencer President and COO strengthens our ability to sustain high growth and leverage the breadth of our portfolio,” ...

December 4, 2025 1 EN
SYK STRYKER CORPORA...

Stryker Corporation - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

SYK STRYKER CORPORATION
12/03/25 December 3, 2025 1 EN
Free Trial
SYK STRYKER CORPORA...

Stryker Corp: 1 director

A director at Stryker Corp sold 520,000 shares at 355.012USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

SYK STRYKER CORPORATION
11/07/25 November 7, 2025 1 EN
 PRESS RELEASE
Free
SYK STRYKER CORPORA...

Stryker reports third quarter 2025 operating results

Stryker reports third quarter 2025 operating results Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organ...

October 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch